Search

everythinglearnresearchcommunity

for

Search:↓

Cancer survivors need better skin care to improve their quality of life.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Baldness (androgenic alopecia) could be a risk factor for prostate cancer.

Childhood cancer diagnosis leads to long-term physical and emotional health issues in parents.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Pancreatic cancer pain management is inadequate due to the disease's severity and limited effectiveness of treatments.

Bald men should protect their scalps from the sun to reduce skin cancer risk.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

Self-care strategies, especially diet and lifestyle changes, help manage cancer treatment symptoms.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Carcinoma patients may have lower zinc levels in their hair.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Financial support and better counseling are needed to make chemotherapy more affordable and manageable for women in Pakistan.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Addressing hair loss's psychological effects with mental health support is crucial for cancer survivors.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.